CRP and neoplasm: A prospective cohort study of 1042 melanoma patients [14] found a significant association of low 25OHD levels with worse melanoma prognostic factors such as high tumor thickness, ulcerated tumor, advanced melanoma stage, and increased levels of C-reactive protein (CRP), an important biomarker of inflammation and cardiovascular risk [15].